Daughters retained stem cell identity as judged by bulge stem cell markers CD34 and LHX2, and by factors such as TCF4 and SOX9, which are expressed but not exclusively by HF stem cells (Figure 2D and Figure 2—figure supplement 1A). The gene discussed is CD34; the disease is hydrops fetalis.